bill gates foundation press release , page-15

Good post Zoeller - the risk I see is the reverse -

ALERE is already the market leader in lateral flow rapid tests with around 40-50% of the $5b plus market

So lets say each percentage point of market share is worth $50m pa - The threat is that ALERE/BBI dont use Mixngo as they have the most to lose from up and coming companies

So if they lost say 5% market share it would be a loss to ALERE of $250m in revenue pa - Over 10 years thats $2.5b lost

Anyone see the value of MIXNGO here :)

Interesting times ahead - Also interesting timing for the BBI IPO IMO